QIAGEN N.V. (QGEN) recently launched the digital PCR (polymerase chain reaction) Custom Assay Design Tool for copy number variation (CNV) analysis for use on the QIAcuity digital PCR (dPCR) platform. Alongside this, the company announced several other enhancements in its GeneGlobe Design and Analysis Hub — a comprehensive research platform that integrates pre-designed assays with a database of more than 10,000 biological entities, including genes, miRNAs and pathways. The latest developments aim to support ...